Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular Schwannomas
Part of paid clinical trials in Milwaukee, Wisconsin.
- Sponsor
- Medical College of Wisconsin
- Study ID
- NCT05702749
- Status
- Recruiting
Conditions
- Vestibular Schwannoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Microsurgical resection of VS — PROCEDUREMicrosurgical resection of VSs can be accomplished by three approaches including middle cranial fossa, retrosigmoid, and translabyrinthine. The surgical approach utilized is typically selected on the basis of tumor location and size, and patient age and hearing status.
- Stereotactic radiosurgery — RADIATIONRadiation therapy will be delivered using single fraction stereotactic radiosurgery with Gamma knife technology, or linear accelerator following institutional standard of care.
- PREHAB — OTHERA PREHAB visit will be done once weekly for 3 weeks to determine exercise regimen prior to surgery or radiotherapy. Therapy includes balance exercises (twice daily), gaze stabilization exercises (12-20 minutes daily), and habituation exercises (as applicable).
Study Details
The study is a pilot efficacy study. The investigators aim to estimate mean baseline and post-treatment balance scores among Vestibular Schwannomas (VS) patients undergoing pretreatment rehab (PREHAB) or no PREHAB when managed with either surgery or radiosurgery.
Key Dates
- Start date
- Jan 22, 2024
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 36 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Active Comparator: Intervention: PREHAB and SurgeryPREHAB exercises will be determined during the physical therapy visit (1x/week) and completed daily with varying frequency for three weeks. Subjects will undergo microsurgical resection of VS.
- Placebo Comparator: Control: Surgery (No PREHAB)Subjects will undergo microsurgical resection of VS.
- Active Comparator: Intervention: PREHAB and SRSPREHAB exercises will be determined during the physical therapy visit (1x/week) and completed daily with varying frequency for three weeks. Subjects will undergo stereotactic radiosurgery.
- Placebo Comparator: Control: SRS (No PREHAB)Subjects will undergo stereotactic radiosurgery.
Primary Outcome Measure
Sensory Organization Test Score at Post-Treatment Assessments [ Time Frame: Post-treatment 1 week ]
Central Contacts
- Medical College of Wisconsin Cancer Center Clinical Trials Office866-680-0505
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Froedtert Hospital and the Medical College of Wisconsin | Milwaukee | Wisconsin | 53226 | Michael Harris, MD |
Find similar trials in Milwaukee, WI
Related Studies
- Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)PHASE2 · Recruiting · Scott R. Plotkin, MD, PhD · Los Angeles, California
- StableEyes With Active NeurofeedbackRecruiting · Johns Hopkins University · Baltimore, Maryland
- Anti-VEGF Gene Therapy Trial for Vestibular SchwannomaPHASE1/PHASE2 · Recruiting · Akouos, Inc. · Baltimore, Maryland
- Long Term Follow-up Study of AAVAnc80-antiVEGF Gene TherapyEnrolling By Invitation · Akouos, Inc. · Dallas, Texas